Introduction
Atherosclerosis is a leading cause of death and disability worldwide with 17.3 million deaths per year [1] [2] [3] , and is projected to increase significantly over the next two decades 4 . Approximately 75% of acute coronary events and 60% of symptomatic carotid artery disease are caused by rupture of vulnerable plaques [5] [6] [7] [8] . Over the last decade, angiogenesis has been the target of intense investigation as it is the critical source of plaque hemorrhage 9 and rupture 8, 10, 11 , ultimately responsible for the sudden onset of myocardial infarction and stroke 9, 12 .
Therefore, identifying new angiogenic factors and signaling pathways that can facilitate the development of tailored therapies for plaque stabilization is of great necessity.
Tissue Factor (TF), also known as Full Length-Tissue Factor (fl-TF), is an integralmembrane glycoprotein (47kDa) that is implicated in tumor growth, angiogenesis and metastasis [13] [14] [15] and also abundantly present in the lipid-rich core of plaques where it is considered a major determinant of plaque thrombogenicity upon rupture 16 .
More recently, a naturally occurring isoform of human fl-TF named Alternatively Spliced
Tissue Factor (asTF) was described. Through alternative splicing of the primary RNA transcript the transmembrane and cytoplasmic domains of fl-TF are replaced with a unique COOHterminal domain in asTF 17 . asTF is a non-membrane anchored molecule of 27kDa that, while retaining most of the contact sites for coagulation factor VIIa, lacks large portions of an exosite for macromolecular substrates 18 . As a result, asTF has no appreciable procoagulant activity and it is believed to play a more prominent role in promoting angiogenesis 19, 20 . Unlike fl-TF, asTF exhibits angiogenic activity via integrin ligation and activation of Focal Adhesion Kinase (FAK) in a factor VIIa and Protease-Activated Receptor-2 (PAR-2) independent manner 19, [21] [22] [23] . In addition to its expression in pancreatic, lung, breast and cervical cancer 19, 21, 24 , asTF has been Tissue Factor (TF), also known as Full Length-Tissue Factor (fl-TF), is an an n i int nt n eg eg egra a ral-l-l membrane glycoprotein (47kDa) that is implicated in tumor growth, angiogenesis and me meta ta tast st sta as asis is is 13-13-13-15 15 1 a and nd nd a also abundantly present in th he e e lip p pid-rich core of of of pla aqu qu ques e where it is considered a m ma majo j r determ min in inan n nt t of of o p p pla la laqu qu que e e t thr hrom om omb bo og g geni ic ci c t t ty upo po pon r ru rup pt ptur ur re e 16 16 .
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To test the hypothesis that asTF plays a role in atherosclerosis, we analyzed its expression and cellular distribution in complicated and uncomplicated human atherosclerotic plaques.
Secondly, we investigated the integrin signal transduction pathways to identify new angiogenic signaling and effector(s) of asTF. Finally, we evaluated the impact of asTF overexpression on neointima formation and neovascularization in a murine model of accelerated atherosclerosis.
Methods
Please refer to the Methods section in the Data Supplements for a detailed description and Supplemental Table 1 for primer sequences used for conventional PCR.
Human Samples
Human carotid specimens (n=10) were obtained from patients undergoing carotid endarterectomy and the Institutional Biorepository/Biospecimen Bank. Their use was approved by the Institutional Review Board of the Icahn School of Medicine at Mount Sinai and subjects gave informed, written consent. Immediately after surgery, carotid plaques were processed by transverse dissection at the site of maximum plaque diameter 28, 29 . One cross-sectional half of the entire plaque was fixed in formalin and embedded in paraffin for histopathology. The other half was flash frozen in liquid nitrogen and stored at -80°C for further analysis. Paraffin blocks of coronary plaques (n=8) were from patients presenting with stable angina (n=4) or acute coronary neointima formation and neovascularization in a murine model of accelerated at th he hero ro osc c cle le lero ro rosi si sis. s.
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Effect of asTF on HIF-1 expression
Briefly, endothelial cells were treated with asTF (10 nM) or vehicle for 6-24 hours and HIF-1 protein and mRNA levels were measured by Western blot and PCR respectively. In additional experiments endothelial cells were treated with asTF (10 nM), fl-TF (10 nM) or vehicle for 24-72 hours and HIF-1 protein expression was measured by immunofluorescence and Western blot analysis.
Role of integrin signaling on HIF-1 induction by asTF
Endothelial cells were pre-incubated with blocking antibodies against v, 6, 3 or 1 integrins (10 g/mL) for 30 minutes prior to treatment with asTF (10 nM) for 6 hours and HIF- Ad. gal (MOI of 100) and after 24 hours treated for 8 hours with asTF (10 nM) and HIF-1 upregulation was measured by western blot analysis.
In vivo Matrigel Plug Assay
Eight weeks old C57Bl6 mice were anesthetized and 0.5 mL ice-cold Matrigel (growth factors reduced) was injected s.c.. Matrigel was either supplemented with 10 nM of asTF, fl-TF or PBS (vehicle). VEGF (50 ng/mL) was used as positive control. After 10 days the animals were euthanized, Matrigel plugs harvested and processed for immunohistochemical analysis and vessel density (N/mm 2 ) quantification 34 .
In separate experiments Matrigel was supplemented with asTF (10 nM) or PBS (Vehicle) either in the presence or absence of anti-v, anti-6 , anti-1 , anti-3 integrin subunit blocking antibodies or specific kinase inhibitors. Ten days after injection, matrigel was harvested for neovessel quantification and HIF-1 immunostaining.
Another series of experiments designed to test the hypothesis that VEGF is an angiogenic effector of asTF. Twenty-four hours before Matrigel injection Ad.VEGF-Trap (10 11 vp) or Ad.
Lacz (10 11 vp) were systemically injected as we previusly reported 34 . Animals from each groups (Ad.VEGF-Trap or Ad.LacZ) were then randomized to receive Matrigel supplemented with asTF (10 nM), VEGF (50 ng/mL) or vehicle.
Mouse Model of Carotid Artery Wire Injury and Lentiviral Transduction
ApoE -/-mice (8-week old, C57BL/6 background) were fed with a Western-type diet (Harlan Laboratories) from 2 weeks before surgery continuing throughout the experiment.
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Statistical analysis
All experiments were performed in triplicate (unless otherwise specified) from at least three independent experiments, and data are shown as mean ± SD or median (minimum-maximum), as appropriate. Intra and inter assay coefficients of variation (CV) were calculated to measure variations of results within one experiment and between replicates, respectively. Intra-assay CV were <10% and inter-assay CV were <15% for experiments performed. Normality was assessed Carotid plaques were classified as type IV-V (atheroma or fibroatheroma, respectively; n=5) and type VI (type IV or V plaques complicated by disruption, hemorrhage or thrombosis; n=5).
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Coronary specimens were classified as type IV (n=4) and type VI (n=4) primary lesions. As expected 33 , type IV lesions were from patients with stable angina while type VI specimens from patients with acute coronary events. Figure 1 ).
Of note, we observed a greater expression of both asTF and TF in complicated vs. 
asTF is expressed by macrophages and neovessels within complicated carotid and coronary plaques
To analyze asTF expression in macrophages and vascular endothelial cells, we performed double immunofluorescence labeling for asTF and CD68 (macrophages) as well as asTF and CD31
(vascular endothelial cells) in carotid and coronary human specimens. In agreement with published results, we observed a greater CD68+ cell density in both complicated carotid and coronary plaques vs. uncomplicated plaques (Figure 2A-D) . Importantly, asTF+ cell density was of stained area) compared to uncomplicated ones (Supplemental Figure 1 ).
Cytotoxicity and cell viability
Significant cytotoxicity was observed in cells exposed to asTF and fl-TF at concentrations of 100 and 200nM (Supplemental Figure 4C) . MTT assay showed an increased viability of cells exposed to asTF and fl-TF at up to 10nM vs. controls at 24, 48 and 72 hours (Supplemental Figure 4D ). Based on these findings 10nM concentration was employed for all further studies.
In vitro Matrigel assay
A 2.5-fold of increase in capillary-like formation was induced by asTF and fl-TF vs. vehicle.
This effect was similar to that of VEGF, which was used as positive control (Supplemental Figure 5C ). In contrast, no capillary formation was observed when asTF and fl-TF were denatured by boiling at 95°C for 5 minutes, demonstrating that the observed angiogenic activity was protein specific and not dependent on endotoxin contamination (Supplemental Figure 4E ).
In Vivo Matrigel assay
The angiogenic effects of asTF, fl-TF were also investigated using the in vivo Matrigel assay.
The results of these experiments confirmed significantly higher neovessel formation induced by asTF, fl-TF and VEGF vs. vehicle. However, asTF exhibits greater angiogenic activity vs. fl-TF and VEGF (Supplemental Figure 5D ).
asTF induces HIF-1 up-regulation
Since the angiogenic activity of asTF is mediated via binding to integrins 19 and integrin signal A 2.5-fold of increase in capillary-like formation was induced by asTF and fl-TF F vs s s. ve ve vehi hi hicl cl cle. e. e
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A significant HIF-1 protein up-regulation was detected in endothelial cells treated with asTF but not with fl-TF. This increase was dose-dependent ( Figure 3A) and was apparent as early as 6
hours with a maximum expression at 12-24 hours ( Figure 3B ). In contrast, no effect was observed on HIF-1 ( Figure 3C ). For the first 24 hours the increase of HIF-1 was restricted to the cytoplasm followed by a progressive translocation to the nucleus of the cells (48 and 72 hours; Figure 3D protein was also observed in the conditioned media of cells treated with asTF ( Figure 6B ).
The contribution of VEGF to the angiogenic activity of asTF was investigated in vivo using an adenovirus vector-encoding the receptor chimera VEGF-Trap R1R2 . As expected, the angiogenic activity of VEGF was completely abolished in mice overexpressing VEGF-Trap vs.
LacZ controls. Remarkably, the angiogenic activity of asTF was inhibited in mice expression was significantly reduced in dn-Akt transduced cells vs. Ad. Gal (Fi ig g gure r r 5 5 5F F F), ), ), uggesting a role of Akt pathway in HIF-1 up-regulation.
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These observations are consistent with the involvement of asTF in the angiogenic switch of unstable atherosclerotic plaques. In light of the observed higher expression of asTF in plaques from patients with acute coronary events vs. lesions from patients with stable angina, it is logical to speculate that asTF may contribute to the onset of coronary events.
Remarkably, asTF influences all critical phases involved in the formation of new blood vessels such as endothelial cells' migration, proliferation and differentiation into capillaries 40 .
Increased proliferation of endothelial cells treated with asTF involves the expression Cyclin D1
showing an early up-regulation followed by down-regulation, reflecting the typical Cyclin D1 rise early in G1 followed by its rapid decline in G1/S-phase when DNA replication occurs 41 . Colocalization of asTF with the proliferation marker Ki67 was observed in complicated plaques highly expressing asTF, suggesting that asTF promotes cell proliferation in human Others could only observe the haptotatic activity and could not detect any proliferative effect of asTF on endothelial cells 19 ; however, in these studies different approaches and higher concentrations of asTF (100nM), which we found to be cytotoxic, were used.
We observed a greater angiogenic potency of asTF vs. fl-TF in vivo. Of note, this effect was observed using equipotent concentrations of tissue factor isoforms and VEGF when their activities were tested in vitro. Although suggestive of a greater angiogenic potency of asTF vs.
fl-TF, the pathophysiological relevance of these findings is difficult to extrapolate to atherosclerotic disease. In fact, the relative expression of fl-TF and asTF is in favor of fl-TF in human atherosclerotic plaques and it remains undetermined how much asTF is expressed in vivo.
Moreover, in our studies we used re-lipidated fl-TF to mimic the effect of circulating fl-TF 42, 43 , an approach that does not reflect the proteome complexity of circulating microparticles carrying fl-TF in humans.
Despite these limitations, our findings highlight the possibility that asTF activates specific signaling pathways. In separate experiments we observed that asTF but not fl-TF an n a a app p roach th hat at t d doe oes s no o ot t r re refl fl fle ec ect t t t the he he p pro rot teom m me e e comp mp m le exi xi xity ty o of f f ci cir r rcu ul ulat atin in ing g mi mi icr cr crop opar ar rti ti icl cl cles es c c car arry ry yin in ng fl l-T -T TF F F in in in h hum um uman ans s. .
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The observed significant dose dependent up-regulation of HIF-1 mRNA suggests that asTF regulates HIF-1 at the transcriptional level. In fact, regulation of HIF-1 protein degradation, which under normoxic conditions occurs via its hydroxylation, binding to pVHL, poly-ubiquitylation and ultimately proteasomal degradation, is the most recognized mechanism for HIF-1 stabilization resulting in HIF-1 heterodimer formation 44 . Interestingly, the detection of polyubiquinated forms of HIF-1 demonstrates that asTF does not interfere with polyubiquitination, a required steps for proteasomal degradation. Of note, the inhibition of HIF-1 protein synthesis by cycloheximide suggests that asTF may increase de-novo protein synthesis via increased HIF-1 mRNA transcription.
In previous studies, asTF was found to oligomerize integrins and activate downstream signaling to promote endothelial cell migration and capillary formation in vitro 19 . However, in vitro conditions may not reflect the complexity of physiological interactions (i.e. blood flow, interactions to cells and matrices) occurring in vivo. Here, we report that the downstream signaling events activated by asTF through integrin activation are relevant for the angiogenic activity of asTF in vivo. A critical role of 3 -, 6 -and 1 -integrins in mediating the angiogenic activity of asTF was demonstrated by the significant reduction of neovessels formation induced by asTF in vivo upon integrin inhibition. We have also demonstrated that HIF-1 up-regulation induced by asTF is mediated via integrin activation. Specifically, it was observed that 3, 1 and 6 -integrin blockade was associated with significant reduction of HIF-1 up-regulation by asTF.
In contrast, no effect was observed in the presence of v blockade.
In support of the validity of our experimental conditions, the formation of large vessels with anti-3 neutralizing antibody alone was expected and in accord with previous findings revealing paradoxically increased angiogenesis via VEGFR-2 up-regulation 45 .
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Increased expression of HIF-1 was detected in complicated plaques with high levels of asTF, findings that support the pathophysiological importance of the proposed mechanism in the progression and complications of atherosclerotic disease. Remarkably, plaque neovascularization was significantly higher in injured and asTF-transduced arterial vessels.
In previous studies it was determined that a 50% reduction of TF, in all cells or in hematopoietic cells only in ApoE-/-and LDLR-/-mice, respectively, does not affect atherosclerosis development 50 . In our study we found that asTF overexpression increase neointima formation and lesion's neovascularization following arterial injury in ApoE-/-mice fed a Western-type diet. In line with the possibility of a pathophysiological effect of asTF on atherosclerosis progression and complications is the observation that asTF is highly expressed within advanced human carotid and coronary plaques complicated by hemorrhage and/or disruption.
Conclusions
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